Skip to NavigationSkip to content

Russia claims it has completed the first human trial for COVID-19 vaccine

Published on 13/07/20 at 11:07am
Photo by President of Russia

Russia has become the first country to complete a COVID-19 vaccine trial on humans, according to the Russian News Agency.

Clinical trials were conducted on volunteers at the Sechenov First Moscow State Medical University and involved 38 people in two separate groups. The vaccine proved to be effective and safe. Vadim Tarasov, the Director of the Institute for Translational Medicine and Biotechnology said: “Sechenov University has successfully completed tests on volunteers of the world’s first vaccine against coronavirus.

“Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research center that is able to participate in the creation of such important and complex products as drug. We worked with this vaccine, starting with preclinical studies and protocol development.”

The two volunteer groups will be discharged on 15 and 20 July and will remain under medical supervision. Prior to the human trials, the vaccine was tested for its toxicity, safety, immunogenicity and effectiveness in large and small animals at the Russian Defence Ministry’s 48th Central Research Institute.

The vaccine is being developed and produced by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology along with the Russian defence ministry.

Conor Kavanagh


I'm glad to hear this news. So fast so good, the number of infected case increases really fast recent, no matter which country succeed first. And the number of new case in Russia is also really high now. 

hotmail com login

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches